Evidence map›Paper›PMID 36677061›Full record

ArticleMetabolites2023

Anti-

Hatun A Alomar, Wafaa M Elkady, Marwa M Abdel-Aziz, Taghreed A Ibrahim, Noha Fathallah

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Therapeutic advances and future directions inFrontiers in microbiology · 2025
    Review
  6. Review
  7. The Different Phytochemical Profiles ofMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Hatun A AlomarPharmacology and Toxicology Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-7495-0592
Wafaa M ElkadyDepartment of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt.ORCID 0000-0002-7656-3892
Marwa M Abdel-AzizRegional Center for Mycology and Biotechnology (RCMB), Al-Azhar University, Cairo 11651, Egypt.
Taghreed A IbrahimDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-5165-4253
Noha FathallahDepartment of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt.ORCID 0000-0002-7278-732X
Future University in Egypt · EGAl-Azhar University · EGCairo University · EGKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to its rising antibiotic resistance and associated inflammations,

Indexed as

antibacterialanti-inflammatoryessential oilethanolic extractGlucose-6 phosphataseHelicobacter pyloriSalvia officinalis

Identifiers

PMID36677061
PMCPMC9865027
OpenAlexW4316673330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.